Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Malaria"" wg kryterium: Temat


Tytuł :
Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study.
Autorzy :
Hogan AB; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.
Winskill P; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.
Ghani AC; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.
Pokaż więcej
Źródło :
PLoS medicine [PLoS Med] 2020 Nov 30; Vol. 17 (11), pp. e1003377. Date of Electronic Publication: 2020 Nov 30 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Malaria Vaccines*/administration & dosage
Malaria Vaccines*/pharmacology
Models, Theoretical*
Malaria/*prevention & control
Malaria, Falciparum/*prevention & control
Child ; Child, Preschool ; Female ; Ghana ; Humans ; Incidence ; Infant ; Infant, Newborn ; Kenya ; Malaria/epidemiology ; Malaria, Falciparum/epidemiology ; Malawi ; Male ; Public Health/statistics & numerical data
Czasopismo naukowe
Tytuł :
Predicting the public health impact of a malaria transmission-blocking vaccine.
Autorzy :
Challenger JD; Medical Research Council Centre for Global Infections Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom. .
Olivera Mesa D; Medical Research Council Centre for Global Infections Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
Da DF; Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.
Yerbanga RS; Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.; Institut des Sciences et Techniques, Bobo-Dioulasso, Burkina Faso.
Lefèvre T; MIVEGEC, University of Montpellier, CNRS, IRD, Montpellier, France.; Centre de Recherche en Écologie et Évolution de la Santé (CREES), Montpellier, France.
Cohuet A; MIVEGEC, University of Montpellier, CNRS, IRD, Montpellier, France.
Churcher TS; Medical Research Council Centre for Global Infections Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Mar 08; Vol. 12 (1), pp. 1494. Date of Electronic Publication: 2021 Mar 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Public Health*
Malaria/*prevention & control
Malaria/*transmission
Malaria Vaccines/*immunology
Adolescent ; Adult ; Burkina Faso/epidemiology ; Child ; Child, Preschool ; Humans ; Infant ; Malaria/epidemiology ; Malaria, Falciparum/prevention & control ; Middle Aged ; Prevalence ; Vaccination ; Young Adult
Czasopismo naukowe
Tytuł :
Genetic diversity and natural selection on the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium falciparum on Bioko Island, Equatorial Guinea and global comparative analysis.
Autorzy :
Lin LY; School of Food Engineering and Biotechnology, Hanshan Normal University, Chaozhou, Guangdong, People's Republic of China.
Huang HY; Department of Medical Laboratory, Chaozhou People's Hospital Affiliated to Shantou University Medical College, Chaozhou, Guangdong, People's Republic of China.; Shantou University Medical College, Shantou, Guangdong, People's Republic of China.
Liang XY; Department of Medical Laboratory, Huizhou Central Hospital, Huizhou, Guangdong, People's Republic of China.
Xie DD; Department of Medical Laboratory, Foshan Second People's Hospital, Foshan, Guangdong, People's Republic of China.; The Chinese Medical Aid Team To the Republic of Equatorial Guinea, Guangzhou, Guangdong, People's Republic of China.
Chen JT; Department of Medical Laboratory, Huizhou Central Hospital, Huizhou, Guangdong, People's Republic of China.; The Chinese Medical Aid Team To the Republic of Equatorial Guinea, Guangzhou, Guangdong, People's Republic of China.
Wei HG; School of Clinical Medicine, Youjiang Medical University for Nationalities, Baise, China.
Huang WY; School of Clinical Medicine, Youjiang Medical University for Nationalities, Baise, China.
Ehapo CS; Department of Medical Laboratory, Malabo Regional Hospital, Malabo, Equatorial Guinea.
Eyi UM; Department of Medical Laboratory, Malabo Regional Hospital, Malabo, Equatorial Guinea.
Li J; Department of Human Parasitology, School of Basic Medical Sciences, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.; Department of Infectious Diseases, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.
Wang JL; School of Clinical Medicine, Youjiang Medical University for Nationalities, Baise, China.
Zheng YZ; School of Food Engineering and Biotechnology, Hanshan Normal University, Chaozhou, Guangdong, People's Republic of China.
Zha GC; School of Food Engineering and Biotechnology, Hanshan Normal University, Chaozhou, Guangdong, People's Republic of China.
Wang YL; School of Clinical Medicine, Youjiang Medical University for Nationalities, Baise, China.
Chen WZ; Department of Medical Laboratory, Chaozhou People's Hospital Affiliated to Shantou University Medical College, Chaozhou, Guangdong, People's Republic of China.; Shantou University Medical College, Shantou, Guangdong, People's Republic of China.
Liu XZ; Department of Medical Laboratory, Chaozhou People's Hospital Affiliated to Shantou University Medical College, Chaozhou, Guangdong, People's Republic of China.; Shantou University Medical College, Shantou, Guangdong, People's Republic of China.
Mo HT; Department of Medical Laboratory, Chaozhou People's Hospital Affiliated to Shantou University Medical College, Chaozhou, Guangdong, People's Republic of China.; Shantou University Medical College, Shantou, Guangdong, People's Republic of China.
Chen XY; Department of Medical Laboratory, Chaozhou People's Hospital Affiliated to Shantou University Medical College, Chaozhou, Guangdong, People's Republic of China.; Shantou University Medical College, Shantou, Guangdong, People's Republic of China.
Lin M; School of Food Engineering and Biotechnology, Hanshan Normal University, Chaozhou, Guangdong, People's Republic of China. .; Department of Medical Laboratory, Chaozhou People's Hospital Affiliated to Shantou University Medical College, Chaozhou, Guangdong, People's Republic of China. .; Shantou University Medical College, Shantou, Guangdong, People's Republic of China. .
Pokaż więcej
Źródło :
Malaria journal [Malar J] 2021 Mar 02; Vol. 20 (1), pp. 124. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Journal Article
MeSH Terms :
Malaria, Falciparum/*parasitology
Plasmodium falciparum/*genetics
Protozoan Proteins/*genetics
Epitopes ; Equatorial Guinea/epidemiology ; Gene Frequency ; Genetic Variation ; Haplotypes ; Humans ; Malaria Vaccines ; Malaria, Falciparum/epidemiology ; Malaria, Falciparum/immunology ; Plasmodium falciparum/immunology ; Polymorphism, Genetic ; Protozoan Proteins/chemistry ; Protozoan Proteins/immunology ; Selection, Genetic
Czasopismo naukowe
Tytuł :
Mechanisms and targets of Fcγ-receptor mediated immunity to malaria sporozoites.
Autorzy :
Feng G; Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.; Department of Medicine and Doherty Institute, The University of Melbourne, Melbourne, VIC, Australia.
Wines BD; Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.; Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, Australia.
Kurtovic L; Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.; Central Clinical School, Monash University, Melbourne, VIC, Australia.
Chan JA; Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.; Central Clinical School, Monash University, Melbourne, VIC, Australia.
Boeuf P; Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.; Department of Medicine and Doherty Institute, The University of Melbourne, Melbourne, VIC, Australia.
Mollard V; School of BioSciences, The University of Melbourne, Melbourne, VIC, Australia.
Cozijnsen A; School of BioSciences, The University of Melbourne, Melbourne, VIC, Australia.
Drew DR; Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.
Center RJ; Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.; Department of Medicine and Doherty Institute, The University of Melbourne, Melbourne, VIC, Australia.
Marshall DL; Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.; Central Clinical School, Monash University, Melbourne, VIC, Australia.
Chishimba S; Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.; Department of Medicine and Doherty Institute, The University of Melbourne, Melbourne, VIC, Australia.
McFadden GI; School of BioSciences, The University of Melbourne, Melbourne, VIC, Australia.
Dent AE; Centre for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
Chelimo K; Department of Biomedical Science and Technology, Maseno University, Kisumu, Kenya.
Boyle MJ; Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.; Department of Immunology, IMR-Berghofer Institute, Herston, QLD, Australia.
Kazura JW; Centre for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
Hogarth PM; Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.; Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, Australia.
Beeson JG; Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia. .; Department of Medicine and Doherty Institute, The University of Melbourne, Melbourne, VIC, Australia. .; Central Clinical School, Monash University, Melbourne, VIC, Australia. .; Department of Microbiology, Monash University, Melbourne, VIC, Australia. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Mar 19; Vol. 12 (1), pp. 1742. Date of Electronic Publication: 2021 Mar 19.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunity, Humoral*
Malaria/*immunology
Malaria/*prevention & control
Receptors, IgG/*immunology
Sporozoites/*immunology
Adult ; Aged ; Antibodies, Protozoan/immunology ; Child ; Female ; Humans ; Kenya ; Malaria Vaccines/immunology ; Male ; Middle Aged ; Monocytes/immunology ; Neutrophils/immunology ; Phagocytosis/immunology ; Plasmodium falciparum/immunology ; Receptors, IgG/metabolism ; THP-1 Cells ; Young Adult
Czasopismo naukowe
Tytuł :
A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes.
Autorzy :
Coelho CH; Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Tang WK; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Burkhardt M; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Galson JD; Division of Immunology and Children's Research Center, University Children's Hospital Zurich, University of Zurich (UZH), Zurich, Switzerland.; Alchemab Therapeutics Ltd, 55-56 Russell Square, London, UK.
Muratova O; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Salinas ND; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Alves E Silva TL; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Reiter K; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
MacDonald NJ; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Nguyen V; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Herrera R; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Shimp R; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Narum DL; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Byrne-Steele M; iRepertoire Inc., Huntsville, AL, USA.
Pan W; iRepertoire Inc., Huntsville, AL, USA.
Hou X; iRepertoire Inc., Huntsville, AL, USA.
Brown B; iRepertoire Inc., Huntsville, AL, USA.
Eisenhower M; iRepertoire Inc., Huntsville, AL, USA.
Han J; iRepertoire Inc., Huntsville, AL, USA.
Jenkins BJ; Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Doritchamou JYA; Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Smelkinson MG; Biological Imaging Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Vega-Rodríguez J; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Trück J; Division of Immunology and Children's Research Center, University Children's Hospital Zurich, University of Zurich (UZH), Zurich, Switzerland.
Taylor JJ; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Sagara I; Malaria Research and Training Center, University of Sciences, Techniques, and Technology, Bamako, Mali.
Renn JP; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Tolia NH; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. .
Duffy PE; Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. .; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Mar 19; Vol. 12 (1), pp. 1750. Date of Electronic Publication: 2021 Mar 19.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal/*pharmacology
Antibodies, Protozoan/*pharmacology
Epitopes/*immunology
Germ Cells/*immunology
Malaria, Falciparum/*prevention & control
Plasmodium falciparum/*drug effects
Adult ; Animals ; Antibodies, Monoclonal/immunology ; Antibodies, Protozoan/immunology ; Antigens, Protozoan/chemistry ; Antigens, Protozoan/immunology ; Binding Sites ; Cells, Cultured ; Epitopes/chemistry ; Host-Parasite Interactions/drug effects ; Host-Parasite Interactions/immunology ; Humans ; Malaria Vaccines/administration & dosage ; Malaria Vaccines/immunology ; Malaria, Falciparum/parasitology ; Malaria, Falciparum/transmission ; Mosquito Vectors/parasitology ; Plasmodium falciparum/immunology ; Plasmodium falciparum/physiology ; Protein Conformation ; Protozoan Proteins/chemistry ; Protozoan Proteins/immunology
Czasopismo naukowe
Tytuł :
Magneto-optical diagnosis of symptomatic malaria in Papua New Guinea.
Autorzy :
Arndt L; Institute of Natural Materials Technology, University of Technology, Dresden, Germany.
Koleala T; Vector-borne Diseases Unit, PNG Institute of Medical Research, Madang, Madang Province, Papua New Guinea.
Orbán Á; Department of Physics, Budapest University of Technology and Economics, Budapest, Hungary.
Ibam C; Vector-borne Diseases Unit, PNG Institute of Medical Research, Madang, Madang Province, Papua New Guinea.
Lufele E; Vector-borne Diseases Unit, PNG Institute of Medical Research, Madang, Madang Province, Papua New Guinea.
Timinao L; Vector-borne Diseases Unit, PNG Institute of Medical Research, Madang, Madang Province, Papua New Guinea.; Australian Institute of Tropical Health and Medicine, James Cook University, Smithfield, QLD, Australia.
Lorry L; Vector-borne Diseases Unit, PNG Institute of Medical Research, Madang, Madang Province, Papua New Guinea.
Butykai Á; Department of Physics, Budapest University of Technology and Economics, Budapest, Hungary.
Kaman P; Vector-borne Diseases Unit, PNG Institute of Medical Research, Madang, Madang Province, Papua New Guinea.
Molnár AP; Department of Physics, Budapest University of Technology and Economics, Budapest, Hungary.
Krohns S; Experimental Physics 5, Center for Electronic Correlations and Magnetism, University of Augsburg, Augsburg, Germany.
Nate E; Vector-borne Diseases Unit, PNG Institute of Medical Research, Madang, Madang Province, Papua New Guinea.
Kucsera I; National Public Health Center, Budapest, Hungary.
Orosz E; National Public Health Center, Budapest, Hungary.
Moore B; School of Pharmacy, Curtin University, Bentley, WA, Australia.
Robinson LJ; Vector-borne Diseases Unit, PNG Institute of Medical Research, Madang, Madang Province, Papua New Guinea.; Burnet Institute, Melbourne, VIC, Australia.
Laman M; Vector-borne Diseases Unit, PNG Institute of Medical Research, Madang, Madang Province, Papua New Guinea.
Kézsmárki I; Department of Physics, Budapest University of Technology and Economics, Budapest, Hungary. .; Experimental Physics 5, Center for Electronic Correlations and Magnetism, University of Augsburg, Augsburg, Germany. .
Karl S; Vector-borne Diseases Unit, PNG Institute of Medical Research, Madang, Madang Province, Papua New Guinea. .; Australian Institute of Tropical Health and Medicine, James Cook University, Smithfield, QLD, Australia. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Feb 12; Vol. 12 (1), pp. 969. Date of Electronic Publication: 2021 Feb 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Diagnostic Tests, Routine/*methods
Malaria/*diagnosis
Microscopy/*methods
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Hemeproteins ; Humans ; Malaria/parasitology ; Malaria, Vivax/diagnosis ; Malaria, Vivax/parasitology ; Male ; Middle Aged ; Optical Devices ; Papua New Guinea ; Plasmodium vivax/genetics ; Polymerase Chain Reaction/methods ; Sensitivity and Specificity ; Young Adult
Czasopismo naukowe
Tytuł :
Malaria trends in Ethiopian highlands track the 2000 'slowdown' in global warming.
Autorzy :
Rodó X; ICREA and CLIMA (Climate and Health) Program, ISGlobal, Barcelona, Spain.
Martinez PP; Department of Epidemiology, Center for Communicable Disease Dynamics, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.; Department of Microbiology and Department of Statistics, University of Illinois at Urbana, Champaign, Champaign, IL, USA.
Siraj A; Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA.
Pascual M; Department of Ecology and Evolution, University of Chicago, Chicago, IL, USA. .; Santa Fe Institute, Santa Fe, NM, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Mar 10; Vol. 12 (1), pp. 1555. Date of Electronic Publication: 2021 Mar 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Malaria/*epidemiology
Africa, Eastern/epidemiology ; Global Warming ; Humans ; Incidence ; Malaria, Falciparum/epidemiology ; Plasmodium falciparum/pathogenicity ; Plasmodium vivax/pathogenicity ; Temperature
Czasopismo naukowe
Tytuł :
Predictors of outcome in childhood Plasmodium falciparum malaria.
Autorzy :
Patel H; Section of Paediatric Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.
Dunican C; Section of Paediatric Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.
Cunnington AJ; Section of Paediatric Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.
Pokaż więcej
Źródło :
Virulence [Virulence] 2020 Dec; Vol. 11 (1), pp. 199-221.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Prognosis*
Malaria, Falciparum/*complications
Malaria, Falciparum/*physiopathology
Acidosis/complications ; Anemia/complications ; Biomarkers ; Child ; Coinfection/complications ; Hemorrhage/complications ; Humans ; Jaundice/complications ; Malaria, Cerebral/complications ; Malaria, Cerebral/mortality ; Malaria, Falciparum/mortality ; Nervous System Diseases/complications ; Plasmodium falciparum/physiology ; Renal Insufficiency/complications ; Respiratory Distress Syndrome/complications ; Shock/complications ; Thrombocytopenia/complications
Czasopismo naukowe
Tytuł :
Maximizing Impact: Can Interventions to Prevent Clinical Malaria Reduce Parasite Transmission?
Autorzy :
McCann RS; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: .
Cohee LM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Goupeyou-Youmsi J; MAC Communicable Diseases Action Centre, College of Medicine, University of Malawi, Blantyre, Malawi.
Laufer MK; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Pokaż więcej
Źródło :
Trends in parasitology [Trends Parasitol] 2020 Nov; Vol. 36 (11), pp. 906-913. Date of Electronic Publication: 2020 Sep 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Disease Eradication*
Malaria/*prevention & control
Malaria/*transmission
Animals ; Antimalarials/therapeutic use ; Chemoprevention/standards ; Humans ; Malaria/drug therapy ; Malaria/immunology ; Malaria Vaccines/immunology ; Malaria Vaccines/standards ; Plasmodium/physiology
Czasopismo naukowe
Tytuł :
The molecular basis for peptide-based antimalarial vaccine development targeting erythrocyte invasion by P. falciparum.
Autorzy :
Aza-Conde J; Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia.
Reyes C; Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia; Biomedical and Biological Sciences PhD Programme, Universidad del Rosario, Bogotá, Colombia.
Suárez CF; Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia; School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
Patarroyo MA; Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia; School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
Patarroyo ME; Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia; Faculty of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia; Universidad Santo Tomás, Bogotá, Colombia. Electronic address: .
Pokaż więcej
Źródło :
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2021 Jan 01; Vol. 534, pp. 86-93. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji :
Journal Article
MeSH Terms :
Erythrocytes/*parasitology
Malaria Vaccines/*pharmacology
Plasmodium falciparum/*pathogenicity
Animals ; Antigens, Protozoan/chemistry ; Aotidae ; Carrier Proteins/chemistry ; Epitopes ; Erythrocytes/drug effects ; Histocompatibility Antigens Class II/metabolism ; Host-Parasite Interactions/drug effects ; Humans ; Magnetic Resonance Spectroscopy ; Malaria Vaccines/immunology ; Malaria Vaccines/metabolism ; Malaria, Falciparum/immunology ; Malaria, Falciparum/prevention & control ; Peptides/immunology ; Peptides/metabolism ; Protozoan Proteins/chemistry ; Vaccines, Subunit/immunology ; Vaccines, Subunit/pharmacology
Czasopismo naukowe
Tytuł :
Maintaining focus on administering effective malaria treatment during the COVID-19 pandemic.
Autorzy :
Raman J; Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa; Wits Research Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; University of Pretoria Institute for Sustainable Malaria Control, School of Health Systems and Public Health, University of Pretoria, South Africa. .
Barnes KI
Baker L
Blaylock M
Blumberg L
Frean J
Misiani E
Ukpe IS
Pokaż więcej
Źródło :
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde [S Afr Med J] 2020 Nov 23; Vol. 111 (1), pp. 13-16. Date of Electronic Publication: 2020 Nov 23.
Typ publikacji :
Journal Article
MeSH Terms :
Antimalarials/*therapeutic use
Malaria/*diagnosis
Malaria/*drug therapy
Administration, Intravenous ; Antigens, Protozoan/blood ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Artesunate/therapeutic use ; COVID-19 ; Early Diagnosis ; Early Medical Intervention ; Humans ; Malaria/transmission ; Malaria, Falciparum/diagnosis ; Malaria, Falciparum/drug therapy ; Malaria, Falciparum/transmission ; Microscopy ; Point-of-Care Testing ; Primaquine/therapeutic use ; Protozoan Proteins/blood ; SARS-CoV-2 ; Severity of Illness Index ; South Africa
Czasopismo naukowe
Tytuł :
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.
Autorzy :
Hossain MS; WorldWide Antimalarial Resistance Network (WWARN), Oxford, United Kingdom.; Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; International Centre for Diarrheal Diseases and Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Commons RJ; WorldWide Antimalarial Resistance Network (WWARN), Oxford, United Kingdom.; Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.; Internal Medical Services, Ballarat Health Services, Ballarat, Victoria, Australia.
Douglas NM; Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Thriemer K; Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.
Alemayehu BH; ICAP at Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Amaratunga C; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Anvikar AR; National Institute of Malaria Research, Dwarka, New Delhi, India.
Ashley EA; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.
Asih PBS; Eijkman Institute for Molecular Biology, Jakarta, Indonesia.
Carrara VI; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.
Lon C; Department of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.; Armed Forces Research Institute of Medical Sciences, Phnom Penh, Cambodia.
D'Alessandro U; Medical Research Council Unit The Gambia at LSTMH, Fajara, The Gambia.
Davis TME; Medical School, University of Western Australia, Fremantle Hospital, Fremantle, Australia.
Dondorp AM; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Edstein MD; Australian Defence Force Malaria and Infectious Disease Institute, Enoggera, Brisbane, Australia.
Fairhurst RM; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Ferreira MU; Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Hwang J; US President's Malaria Initiative, Malaria Branch, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.; Global Health Group, University of California San Francisco, San Francisco, California, United States of America.
Janssens B; Médecins Sans Frontieres, Brussels, Belgium.
Karunajeewa H; Melbourne Medical School-Western Health, The University of Melbourne, Melbourne, Australia.; Western Health Chronic Disease Alliance, Sunshine Hospital, St Albans, Melbourne, Australia.
Kiechel JR; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
Ladeia-Andrade S; Laboratory of Parasitic Diseases, Oswaldo Cruz Institute/Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.; Amazonian Malaria Initiative/Amazon Network for the Surveillance of Antimalarial Drug Resistance, Ministry of Health of Brazil, Cruzeiro do Sul, Brazil.
Laman M; Medical School, University of Western Australia, Fremantle Hospital, Fremantle, Australia.; Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea.
Mayxay M; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.; Institute of Research and Education Development (IRED), University of Health Sciences, Ministry of Health, Vientiane, Lao PDR.
McGready R; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.
Moore BR; Medical School, University of Western Australia, Fremantle Hospital, Fremantle, Australia.; School of Pharmacy and Biomedical Sciences, Curtin University, Perth, Australia.
Mueller I; Division of Population Health and Immunity, The Walter & Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Australia.; Parasites and Insect Vectors Department, Institut Pasteur, Paris, France.
Newton PN; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Thuy-Nhien NT; Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam.
Noedl H; MARIB-Malaria Research Initiative Bandarban, Vienna, Austria.
Nosten F; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.
Phyo AP; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Poespoprodjo JR; Mimika District Hospital, Timika, Indonesia.; Timika Malaria Research Programme, Papuan Health and Community Development Foundation, Timika, Indonesia.; Paediatric Research Office, Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, Yogyakarta, Indonesia.
Saunders DL; Division of Medicine, United States Army Research Institute of Infectious Diseases, Ft. Detrick, Maryland, United States of America.
Smithuis F; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.; Medical Action Myanmar, Yangon, Myanmar.
Spring MD; Department of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.
Stepniewska K; WorldWide Antimalarial Resistance Network (WWARN), Oxford, United Kingdom.; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Suon S; National Center for Parasitology, Entomology, and Malaria Control, Phnom Penh, Cambodia.
Suputtamongkol Y; Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Syafruddin D; Eijkman Institute for Molecular Biology, Jakarta, Indonesia.; Department of Parasitology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.
Tran HT; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.; Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam.
Valecha N; National Institute of Malaria Research, Dwarka, New Delhi, India.
Van Herp M; Médecins Sans Frontieres, Brussels, Belgium.
Van Vugt M; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Academic Medical Centre, Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands.
White NJ; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Guerin PJ; WorldWide Antimalarial Resistance Network (WWARN), Oxford, United Kingdom.; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Simpson JA; WorldWide Antimalarial Resistance Network (WWARN), Oxford, United Kingdom.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Price RN; WorldWide Antimalarial Resistance Network (WWARN), Oxford, United Kingdom.; Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Pokaż więcej
Źródło :
PLoS medicine [PLoS Med] 2020 Nov 19; Vol. 17 (11), pp. e1003393. Date of Electronic Publication: 2020 Nov 19 (Print Publication: 2020).
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antimalarials/*therapeutic use
Artemether, Lumefantrine Drug Combination/*therapeutic use
Malaria, Vivax/*drug therapy
Plasmodium vivax/*pathogenicity
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Artemisinins/therapeutic use ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Malaria/drug therapy ; Malaria, Falciparum/drug therapy ; Male ; Middle Aged ; Parasitemia/drug therapy ; Plasmodium vivax/drug effects ; Young Adult
Czasopismo naukowe
Tytuł :
Time for pragmatic, prospective clinical trials to determine the role of empirical antibacterial therapy in critically ill adults hospitalized with malaria.
Autorzy :
Hanson J; The Kirby Institute, University of New South Wales, Sydney, Australia; University of Medicine 2, North Okkalapa Township, Yangon, Myanmar; Myanmar Australia Research Collaboration for Health (MARCH), Yangon, Myanmar. Electronic address: .
Nyein PP; Myanmar Australia Research Collaboration for Health (MARCH), Yangon, Myanmar; Mingaladon Specialist Hospital, Mingaladon Township, Yangon, Myanmar.
Aung NM; University of Medicine 2, North Okkalapa Township, Yangon, Myanmar; Myanmar Australia Research Collaboration for Health (MARCH), Yangon, Myanmar; Insein General Hospital, Insein Township, Yangon, Myanmar.
Kyi MM; University of Medicine 2, North Okkalapa Township, Yangon, Myanmar; Myanmar Australia Research Collaboration for Health (MARCH), Yangon, Myanmar; Insein General Hospital, Insein Township, Yangon, Myanmar.
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Jan; Vol. 102, pp. 28-31. Date of Electronic Publication: 2020 Oct 02.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Coinfection*
Anti-Bacterial Agents/*therapeutic use
Bacteremia/*drug therapy
Bacterial Infections/*drug therapy
Malaria/*complications
Sepsis/*drug therapy
Adult ; Bacteremia/complications ; Bacterial Infections/complications ; Child ; Critical Illness ; Humans ; Malaria, Falciparum/complications ; Parasitemia/complications ; Sepsis/complications
Czasopismo naukowe
Tytuł :
Acquisition and decay of IgM and IgG responses to merozoite antigens after Plasmodium falciparum malaria in Ghanaian children.
Autorzy :
Walker MR; Department of Immunology and Microbiology, Centre for Medical Parasitology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Knudsen AS; Department of Immunology and Microbiology, Centre for Medical Parasitology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Partey FD; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Bassi MR; Department of Immunology and Microbiology, Centre for Medical Parasitology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Frank AM; Department of Immunology and Microbiology, Centre for Medical Parasitology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Castberg FC; Department of Clinical Microbiology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
Sarbah EW; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Ofori MF; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Hviid L; Department of Immunology and Microbiology, Centre for Medical Parasitology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Barfod L; Department of Immunology and Microbiology, Centre for Medical Parasitology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Dec 17; Vol. 15 (12), pp. e0243943. Date of Electronic Publication: 2020 Dec 17 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunoglobulin G/*immunology
Immunoglobulin M/*immunology
Malaria, Falciparum/*immunology
Plasmodium falciparum/*immunology
Adolescent ; Adult ; Aged ; Antibodies, Protozoan/immunology ; Antigens, Protozoan/immunology ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Malaria Vaccines/immunology ; Malaria, Falciparum/parasitology ; Male ; Merozoites/immunology ; Merozoites/pathogenicity ; Middle Aged ; Plasmodium falciparum/pathogenicity ; Young Adult
Czasopismo naukowe
Tytuł :
A novel deep learning-based point-of-care diagnostic method for detecting Plasmodium falciparum with fluorescence digital microscopy.
Autorzy :
Holmström O; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Stenman S; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Suutala A; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Moilanen H; Center of Microscopy and Nanotechnology, University of Oulu, Oulu, Finland.
Kücükel H; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Ngasala B; Department of Women's and Children's Health, International Maternal and Child Health (IMCH), Uppsala University, Uppsala, Sweden.; Department of Medical Entomology and Parasitology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Mårtensson A; Department of Women's and Children's Health, International Maternal and Child Health (IMCH), Uppsala University, Uppsala, Sweden.
Mhamilawa L; Department of Women's and Children's Health, International Maternal and Child Health (IMCH), Uppsala University, Uppsala, Sweden.; Department of Medical Entomology and Parasitology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Aydin-Schmidt B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Lundin M; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Diwan V; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Linder N; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.; Department of Women's and Children's Health, International Maternal and Child Health (IMCH), Uppsala University, Uppsala, Sweden.
Lundin J; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Nov 17; Vol. 15 (11), pp. e0242355. Date of Electronic Publication: 2020 Nov 17 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Diagnostic Tests, Routine/*instrumentation
Diagnostic Tests, Routine/*methods
Malaria, Falciparum/*diagnosis
Adult ; Azure Stains ; Blood Specimen Collection/methods ; Deep Learning ; Fluorescence ; Humans ; Malaria/parasitology ; Malaria, Falciparum/parasitology ; Microscopy, Fluorescence ; Parasitemia/diagnosis ; Plasmodium/parasitology ; Plasmodium falciparum/pathogenicity ; Point-of-Care Testing
Czasopismo naukowe
Tytuł :
Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia.
Autorzy :
Kesely K; Department of Chemistry, Purdue University, West Lafayette, IN, United States of America.; Institute for Drug Discovery, Purdue University, West Lafayette, IN, United States of America.
Noomuna P; Department of Chemistry, Purdue University, West Lafayette, IN, United States of America.; Institute for Drug Discovery, Purdue University, West Lafayette, IN, United States of America.
Vieth M; Eli Lilly and Company, San Diego, CA, United States of America.
Hipskind P; School of Medicine, Indiana University, Bloomington, IN, United States of America.; Clinical Pharmacology R2 402 MDEP, Indianapolis, IN, United States of America.
Haldar K; Galvin Life Science Center, University of Notre Dame, Notre Dame, IN, United States of America.
Pantaleo A; University of Sassari, Sassari, Italy.
Turrini F; University of Torino, Torino, Italy.
Low PS; Department of Chemistry, Purdue University, West Lafayette, IN, United States of America.; Institute for Drug Discovery, Purdue University, West Lafayette, IN, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Nov 12; Vol. 15 (11), pp. e0242372. Date of Electronic Publication: 2020 Nov 12 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Malaria, Falciparum/*drug therapy
Protein Kinase Inhibitors/*pharmacology
Syk Kinase/*antagonists & inhibitors
Animals ; Antimalarials/therapeutic use ; Erythrocytes/drug effects ; Erythrocytes/metabolism ; Female ; Healthy Volunteers ; Humans ; Malaria/drug therapy ; Malaria, Falciparum/parasitology ; Male ; Parasitemia/drug therapy ; Parasites/metabolism ; Peptide Library ; Phosphorylation ; Plasmodium falciparum/drug effects ; Plasmodium falciparum/metabolism ; Plasmodium falciparum/parasitology ; Protein-Tyrosine Kinases/antagonists & inhibitors ; Protein-Tyrosine Kinases/metabolism ; Syk Kinase/metabolism
Czasopismo naukowe
Tytuł :
The immunoglobulin G antibody response to malaria merozoite antigens in asymptomatic children co-infected with malaria and intestinal parasites.
Autorzy :
Ndiabamoh CM; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.; The Biotechnology Center, Nkolbisson, University of Yaoundé I, Yaoundé, Cameroon.
Ekali GL; The Biotechnology Center, Nkolbisson, University of Yaoundé I, Yaoundé, Cameroon.; National AIDS Control Committee, Ministry of Public Health, Yaoundé, Cameroon.
Esemu L; The Biotechnology Center, Nkolbisson, University of Yaoundé I, Yaoundé, Cameroon.; Department of Biochemistry, University of Yaoundé 1, Yaoundé, Cameroon.
Lloyd YM; John A. Burns School of Medicine, University of Hawai'i, Mānoa, Hawaii, United States of America.
Djontu JC; The Biotechnology Center, Nkolbisson, University of Yaoundé I, Yaoundé, Cameroon.
Mbacham W; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.; The Biotechnology Center, Nkolbisson, University of Yaoundé I, Yaoundé, Cameroon.; Department of Biochemistry, University of Yaoundé 1, Yaoundé, Cameroon.
Bigoga J; The Biotechnology Center, Nkolbisson, University of Yaoundé I, Yaoundé, Cameroon.; Department of Biochemistry, University of Yaoundé 1, Yaoundé, Cameroon.
Taylor DW; John A. Burns School of Medicine, University of Hawai'i, Mānoa, Hawaii, United States of America.
Leke RGF; The Biotechnology Center, Nkolbisson, University of Yaoundé I, Yaoundé, Cameroon.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Nov 10; Vol. 15 (11), pp. e0242012. Date of Electronic Publication: 2020 Nov 10 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Coinfection/*epidemiology
Intestinal Diseases, Parasitic/*epidemiology
Malaria, Falciparum/*epidemiology
Adolescent ; Animals ; Antibodies, Protozoan/blood ; Antibody Formation ; Antigens, Protozoan/immunology ; Cameroon/epidemiology ; Child ; Child, Preschool ; Cross-Sectional Studies ; Female ; Humans ; Immunoglobulin G/blood ; Immunologic Tests ; Infant ; Malaria/epidemiology ; Malaria/immunology ; Malaria/parasitology ; Malaria, Falciparum/immunology ; Malaria, Falciparum/parasitology ; Male ; Merozoites/immunology ; Parasites/immunology ; Plasmodium falciparum/immunology ; Prevalence ; Protozoan Proteins/immunology
Czasopismo naukowe
Tytuł :
Malaria elimination using the 1-3-7 approach: lessons from Sampov Loun, Cambodia.
Autorzy :
Kheang ST; University Research Co. LLC, Phnom Penh, Cambodia.
Sovannaroth S; National Malaria Control Program, Phnom Penh, Cambodia.
Barat LM; President's Malaria Initiative/United States Agency for International Development, Washington, DC, USA.
Dysoley L; National Malaria Control Program, Phnom Penh, Cambodia.
Kapella BK; President's Malaria Initiative/Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Po L; National Malaria Control Program, Phnom Penh, Cambodia.
Nguon S; University Research Co. LLC, Phnom Penh, Cambodia.
Gimnig J; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Slot R; President's Malaria Initiative/United States Agency for International Development, Phnom Penh, Cambodia.
Samphornarann T; University Research Co. LLC, Phnom Penh, Cambodia.
Meng SK; University Research Co. LLC, Phnom Penh, Cambodia.
Dissanayake G; President's Malaria Initiative/United States Agency for International Development, Phnom Penh, Cambodia.
AlMossawi HJ; University Research Co., LLC, Chevy Chase, MD, USA.
Longacre C; University Research Co., LLC, Chevy Chase, MD, USA.
Kak N; University Research Co., LLC, Chevy Chase, MD, USA. .
Pokaż więcej
Źródło :
BMC public health [BMC Public Health] 2020 Apr 22; Vol. 20 (1), pp. 544. Date of Electronic Publication: 2020 Apr 22.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Malaria, Falciparum*/diagnosis
Malaria, Falciparum*/epidemiology
Malaria, Falciparum*/therapy
Population Surveillance*
Disease Eradication/*methods
Cambodia/epidemiology ; Disclosure ; Family Characteristics ; Female ; Health Education ; Humans ; Incidence ; Insecticide-Treated Bednets ; Insecticides ; Malaria/epidemiology ; Malaria/therapy ; Mass Screening ; Microscopy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults.
Autorzy :
Moon JE; Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Ockenhouse C; PATH-Malaria Vaccine Initiative, Washington, DC, USA.
Regules JA; Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Vekemans J; GSK Biologicals, Rixensart, Belgium.
Lee C; PATH-Malaria Vaccine Initiative, Washington, DC, USA.
Chuang I; Naval Medical Research Center, Silver Spring, Maryland, USA.
Traskine M; GSK Biologicals, Rixensart, Belgium.
Jongert E; GSK Biologicals, Rixensart, Belgium.
Ivinson K; PATH-Malaria Vaccine Initiative, Washington, DC, USA.
Morelle D; GSK Biologicals, Rixensart, Belgium.
Komisar JL; Naval Medical Research Center, Silver Spring, Maryland, USA.
Lievens M; GSK Biologicals, Rixensart, Belgium.
Sedegah M; Naval Medical Research Center, Silver Spring, Maryland, USA.
Garver LS; Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Sikaffy AK; Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Waters NC; Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Ballou WR; GSK Biologicals, Rixensart, Belgium.
Ofori-Anyinam O; GSK Biologicals, Rixensart, Belgium.
Pokaż więcej
Corporate Authors :
RTS,S Malaria Vaccine Working Group
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Oct 13; Vol. 222 (10), pp. 1681-1691.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Malaria/*immunology
Malaria/*prevention & control
Malaria Vaccines/*administration & dosage
Malaria Vaccines/*immunology
Adolescent ; Adult ; Female ; Humans ; Immunization Schedule ; Infection Control ; Malaria, Falciparum/immunology ; Malaria, Falciparum/prevention & control ; Male ; Middle Aged ; Plasmodium falciparum/immunology ; Vaccination ; Young Adult
Czasopismo naukowe
Tytuł :
Malaria vaccines: facing unknowns.
Autorzy :
Palacpac NMQ; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Horii T; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Pokaż więcej
Źródło :
F1000Research [F1000Res] 2020 Apr 27; Vol. 9. Date of Electronic Publication: 2020 Apr 27 (Print Publication: 2020).
Typ publikacji :
Journal Article; Review
MeSH Terms :
Malaria Vaccines*
Malaria/*prevention & control
Antigens, Protozoan/immunology ; Humans ; Malaria/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies